VMD · Viemed Healthcare, Inc. · Documents

Jul 5

Current report 8-K

Regulation FD disclosure

Jun 9

Current report 8-K

Shareholder vote results, Regulation FD disclosure

May 16

Current report 8-K

Regulation FD disclosure, Other events

May 4

Earnings call

Q4 2021 earnings call

May 4

Current report 8-K

Regulation FD disclosure

May 3

Earnings call

Q1 2022 earnings call

May 3

Current report 8-K

Financial results

May 3

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $32.26M ▲ 13.5% Net income $1.76M ▲ 4.6% Diluted EPS $0.04 ▲ unchanged

Apr 29

Proxy statement DEF 14A

Proxy statement

Apr 29

Proxy statement DEFA14A

Proxy statement

Mar 8

Current report 8-K Events of Mar 7

Regulation FD disclosure, Other events

Mar 7

Current report 8-K

Financial results

Mar 7

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $117.06M ▼ 10.8% Net income $9.13M ▼ 71.1% Diluted EPS $0.22 ▼ 71.8%

Nov 3

Current report 8-K

Regulation FD disclosure

Nov 2

Earnings call

Q3 2021 earnings call

Nov 2

Current report 8-K Events of Nov 1

Financial results

Nov 2

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $29.29M ▼ 12.4% Net income $1.79M ▼ 36.2% Diluted EPS $0.04 ▼ 42.9%

Sep 16

Current report 8-K

Regulation FD disclosure

Aug 6

Current report 8-K Events of Aug 5

Regulation FD disclosure

Aug 3

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $27.4M ▼ 36.1% Net income $1.57M ▼ 91.9% Diluted EPS $0.04 ▼ 91.7%

Aug 2

Earnings call

Q2 2021 earnings call

Aug 2

Current report 8-K

Financial results

Jun 10

Current report 8-K

Change to shareholders' rights, Shareholder vote results, Regulation FD disclosure

May 24

Current report 8-K

Regulation FD disclosure

May 6

Current report 8-K

Regulation FD disclosure

May 3

Earnings call

Q1 2021 earnings call

May 3

Current report 8-K

Financial results

May 3

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Revenue $28.42M ▲ 19.4% Net income $1.68M ▼ 60.3% Diluted EPS $0.04 ▼ 63.6%

Apr 30

Proxy statement DEF 14A Meeting Jun 10, 2021

Proxy statement

Apr 30

Proxy statement DEFA14A

Proxy statement

Apr 9

Proxy statement PRE 14A

Proxy statement

Mar 4

Current report 8-K

Regulation FD disclosure

Mar 3

Earnings call

Q4 2020 earnings call

Mar 3

Current report 8-K

Financial results

Mar 3

Annual report 10-K FY2020, ended Dec 31

Annual report for FY2020

Revenue $131.31M ▲ 63.6% Net income $31.53M ▲ 269.9% Diluted EPS $0.78 ▲ 271.4%

Feb 11

Current report 8-K

Regulation FD disclosure

Jan 7

Current report 8-K Events of Jan 6

Regulation FD disclosure

Dec 21

Current report 8-K

Regulation FD disclosure

Nov 9

Current report 8-K Events of Nov 4

Director or officer change, or executive pay, Regulation FD disclosure

Nov 6

Current report 8-K

Regulation FD disclosure

Nov 5

Earnings call

Q3 2020 earnings call

Nov 5

Current report 8-K Events of Nov 4

Financial results

Nov 4

Quarterly report 10-Q FY2020 Q3, ended Sep 30

Quarterly report for FY2020 Q3

Revenue $33.45M ▲ 64.2% Net income $2.8M ▼ 1.7% Diluted EPS $0.07 ▲ unchanged

Oct 29

Current report 8-K Events of Oct 28

Regulation FD disclosure

Sep 3

Registration statement S-3

Registration statement

Aug 5

Earnings call

Q2 2020 earnings call

Aug 5

Current report 8-K Events of Aug 4

Financial results

Aug 4

Quarterly report 10-Q FY2020 Q2, ended Jun 30

Quarterly report for FY2020 Q2

Revenue $42.85M ▲ 110.8% Net income $19.41M ▲ 1364.0% Diluted EPS $0.48 ▲ 1500.0%

Jun 18

Current report 8-K

Regulation FD disclosure

Jun 11

Current report 8-K

Director or officer change, or executive pay, Shareholder vote results